Hung Do
No más puestos en curso
Perfil
Hung Do fundó Callidus Biopharma, Inc. El Dr. Do es Director Científico de Amicus Therapeutics, Inc. Anteriormente ocupó el cargo de Director y Jefe Científico en Callidus Biopharma, Inc., Jefe de Proyecto en Genzyme Corp. y Director en Novazyme Pharmaceuticals, Inc. Hung Do se doctoró en la Universidad A&M de Texas.
Antiguos cargos conocidos de Hung Do.
| Empresas | Cargo | Fin |
|---|---|---|
Callidus Biopharma, Inc.
 Callidus Biopharma, Inc. BiotechnologyHealth Technology Callidus Biopharma, Inc. develops drug discovery services. The firm focuses on enzyme replacement therapies (ERTs) for lysosomal storage disorders (LSDs). Its novel technology platform is based on attaching a form of the naturally occurring Insulin-like growth factor (IGF-2) to enhance the targeting of therapeutic enzymes to the relevant cells in the body. The company was founded by Cuong Viet Do and Hung Do in 2010 and is headquartered in Bensalem, PA. | Founder | 01/11/2013 |
| AMICUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Novazyme Pharmaceuticals, Inc.
 Novazyme Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Novazyme Pharmaceuticals, Inc. researches and develops methods for modifying recombinantly produced enzymes. It develops a series of novel protein engineering technologies that have been shown in pre-clinical studies to greatly enhance the targeting and uptake of replacement enzymes. Novazyme's technologies also have application for developing advanced monoclonal antibodies and gene therapies. The company is located in Oklahoma City, OK. | Corporate Officer/Principal | - |
Formación de Hung Do.
| Texas A&M University | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AMICUS THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Callidus Biopharma, Inc.
Callidus Biopharma, Inc. BiotechnologyHealth Technology Callidus Biopharma, Inc. develops drug discovery services. The firm focuses on enzyme replacement therapies (ERTs) for lysosomal storage disorders (LSDs). Its novel technology platform is based on attaching a form of the naturally occurring Insulin-like growth factor (IGF-2) to enhance the targeting of therapeutic enzymes to the relevant cells in the body. The company was founded by Cuong Viet Do and Hung Do in 2010 and is headquartered in Bensalem, PA. | Health Technology |
Novazyme Pharmaceuticals, Inc.
Novazyme Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Novazyme Pharmaceuticals, Inc. researches and develops methods for modifying recombinantly produced enzymes. It develops a series of novel protein engineering technologies that have been shown in pre-clinical studies to greatly enhance the targeting and uptake of replacement enzymes. Novazyme's technologies also have application for developing advanced monoclonal antibodies and gene therapies. The company is located in Oklahoma City, OK. | Commercial Services |
- Bolsa de valores
- Insiders
- Hung Do
